ReviewRegenerative therapy2026
Biofabrication strategies for engineered constructs in cardiovascular tissue repair.
Review in Regenerative therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cardiovascular disease remains a major cause of morbidity and mortality worldwide, necessitating a paradigm shift in treatment approaches. Biofabrication, which involves the creation of patient-specific structures for tissue repair, has emerged as a promising approach. Recent advances in tissue engineering and additive manufacturing have accelerated progress in this field, making a comprehensive overview timely. This review examines various biofabrication technologies used in cardiovascular research, highlighting their advantages and disadvantages, and details the advances in biofabricated cardiac patches, valves, vessels, and stents based on papers published over the past decade. By synthesizing findings across studies, we identify emerging trends, current challenges, and potential future directions. This review aims to guide researchers in exploring biofabrication-based strategies for cardiovascular tissue repair.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.